Dr. Agarwal's Health Care Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts less than Nifty Microcap 250 and 2.1 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dr. Agarwal's Health Care Limited has submitted its financial results to the NSE for the period ending March 31, 2025. This is a routine regulatory filing indicating compliance with listing requirements for quarterly/annual results disclosure. The announcement itself is a submission notice and does not contain detailed financial figures, auditor observations, or management commentary. Investors should refer to the accompanying results document for actual revenue, profit, margin, and cash flow data, along with any notes on exceptional items, related party transactions, or contingent liabilities.
No immediate stock price catalyst can be inferred from the submission notice alone; the market reaction will depend on the actual numbers and outlook disclosed in the detailed results document.